Fujitsu Wants to Become Your New GP With the Help of Technology

adobestock_56431429
Tired of Returning your Online Shopping Because it Doesn’t Fit?
October 20, 2016
Design composed of numbers and design elements as a metaphor on the subject of computers, science, math and modern technology
Travel-Expenses Can Now be Reduced Thanks to TravelBank’s AI
October 21, 2016

Fujitsu Wants to Become Your New GP With the Help of Technology

Frame of Mind series. Backdrop of human face wire-frame and fractal elements on the subject of mind, reason, thought, mental powers and mystic consciousness

What springs to mind when hearing the word Fujitsu is not most likely your local GP, but if the Japanese electronics giant will have its way, their artificial intelligent computer system might be your new doctor.

Fujitsu teams up with Kyoto University, and with Professor Yasushi Okunu in the lead they hope to create an AI system capable of both diagnosing a patient and offer treatment suggestions, Asahi Shimbun writes.

The initial plan is that the machine will work as a medical assistant to your personal GP, or a “second doctor that will be present in the room. This new system will analyse the patients genetic codes in order to make its assessments.

“The team also hopes the system will be capable of estimating how gene mutations that have yet to be identified are associated with diseases”, Asahi Shimbun writes.

So when can we expect to have a machine accompanying our GP? The team aims towards having the project put to practice by 2020.

Fujitsu is just one of many companies who are aiming to take AI into the medical sphere, following projects such as IMB’s ‘Watson’ who is now expanding to Germany with the aim of diagnosing rare diseases.

 Statistics from CBS Insights reveals that there has been a leap in deals to companies who are applying healthcare-focused applications, from less than 10 deals in 2011, to 60 in 2015.

CBS Insights writes: “There have already been over 40 deals to AI in healthcare this year as of 6/15/2016, including a Series E round raised by IBM Watson Group-backed Pathway Genomics, and Series A rounds raised Babylon Health (backed by investors including Kinnevik and Google-owned DeepMind Technologies), as well as AiCure (backed by investors including New Leaf Venture Partners and Pritzker Group Venture Capital)”.

In other words, it will be very exciting in the future to see where artificial intelligence can take the medical industry, and AI Business will follow it closely.

This article was originally published at: http://www.asahi.com/ajw/articles/AJ201610190001.html

For the latest news and conversations about AI in business, follow us on Twitterjoin our community onLinkedIn and like us on Facebook.

Leave a Reply

Translate »

We use cookies. By browsing our site you agree to our use of cookies.Accept